Protalix BioTherapeuticsvsUnitedHealth

PLX and UNH stock compared: price, dividend, valuation and results, from SEC filings.

PLX

Protalix BioTherapeutics, Inc.

$3.02

Value $243M

+0.00%
PLX's page

UNH

UnitedHealth Group Incorporated

$342.10

Value $311B

-2.66%
UNH's page

Protalix BioTherapeutics (PLX) has a market value of $243M and UnitedHealth (UNH) $311B. Over the last year, with dividends, PLX moved +60.6% and UNH +11.5%. The P/E is 11.8 for PLX and 19.6 for UNH. Dividend yield: PLX none, UNH 2.65%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    PLX$243M

    UNH$311B

    UNH is 1,276 times PLX

  • Revenue, 12 months

    PLX$85M

    UNH$450B

    UNH is 5,309 times PLX

  • Net income, 12 months

    PLX$21M

    UNH$15.9B

    UNH is 773 times PLX

  • Operating margin

    PLX29.8%

    UNH5.3%

    24.5 points apart

  • ROIC

    PLX31.3%

    UNH11.3%

    20.0 points apart

  • P/E

    PLX11.8

    UNH19.6

    UNH is 1.7 times PLX

  • Dividend yield

    PLX0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    PLX+205.1%

    UNH-17.0%

    222.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

PLX+205.0%

UNH-17.0%

10020030020222023202420252026
Returns by period
PeriodPLXWith dividendsUNHWith dividends
1 year since November 18, 2025+60.6%Price +60.6%+11.5%Price +8.6%
3 years since November 17, 2023+115.7%+29.2% a yearPrice +115.7%-32.4%-12.2% a yearPrice -36.5%
5 years since November 18, 2021+205.1%+25.0% a yearPrice +205.1%-17.0%-3.7% a yearPrice -24.2%
10 years since November 21, 2016-37.1%-4.5% a yearPrice -37.1%+167.4%+10.3% a yearPrice +126.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

PLXProtalix BioTherapeuticsUNHUnitedHealth

Valuation

PLXUNH
Valuation
Price$3.02$342.10
Market value$243M$311B
Enterprise value (EV)$221M$356B
P/E11.819.6
P/E, 5-year median–25.0
P/B3.03.0
EV/EBIT8.814.9
Free cash flow yield6.2%7.4%

Results and growth

PLXUNH
Results and growth
Revenue, 12 months$85M$450B
Net income, 12 months$21M$15.9B
Free cash flow, 12 months$15M$22.8B
Earnings per share, 12 months$0.25$17.52
Revenue growth, year on year-1.2%11.8%
Revenue growth a year, past-3.5%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

PLXUNH
Margins and returns on capital
Gross margin71.2%88.3%
Operating margin29.8%5.3%
Net margin24.3%3.5%
ROIC31.3%11.3%
ROE32.1%15.5%

Balance sheet

PLXUNH
Balance sheet
Cash$22M$28.5B
Total debt$9.1M$74.3B
Net debt / EBITDA-0.81.6
Interest cover–6.2×

Dividends and buybacks

PLXUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: PLX or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Protalix BioTherapeutics or UnitedHealth?

By market value, UnitedHealth ($311B) is about 1,276.1 times Protalix BioTherapeutics ($243M), at today's prices.

How did PLX and UNH stock do over the last 10 years?

Since November 21, 2016, PLX's price moved -37.1% and UNH's +126.4%. With dividends: PLX -37.1% (-4.5% a year), UNH +167.4% (+10.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, PLX or UNH?

The dividend yield at today's price is none for Protalix BioTherapeutics and 2.65% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

What is the P/E of PLX and UNH?

At today's price, the P/E is 11.8 for PLX and 19.6 for UNH. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Protalix BioTherapeutics or UnitedHealth?

Over the last twelve months, the net margin was 24.3% for Protalix BioTherapeutics and 3.5% for UnitedHealth, and the operating margin 29.8% and 5.3%. Revenue was $85M and $450B.

Which is the better investment, Protalix BioTherapeutics or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.